Hypercarbia

Introduction

• Hypercarbia (also known as hypercapnia) refers to an elevated arterial CO₂ concentration (PaCO₂ more than 45 mmHg).¹
• CO₂ plays a crucial role in acid-base balance, vascular tone, and the regulation of respiratory drive.^1,2 Please see the OA summary “Carbon Dioxide: Storage, Transport, and CO₂ Dissociation Curve” for more details. Link
• Under normal conditions, CO₂ is produced by aerobic metabolism and expelled through alveolar ventilation. This balance is governed by several equations:

• PaCO₂, therefore, rises when CO₂ production (V̇CO₂) exceeds alveolar ventilation (V̇A), by any of the following mechanisms:
  • Increased metabolic CO₂ production
  • Decreased tidal volume
  • Increased dead space
  • Decreased respiratory rate
• The degree to which PaCO₂ rises for a given alveolar ventilation depends on underlying physiologic state and is described in Figure 1 below.
• In anesthetic and critical care practice, both permissive hypercapnia, but more often, pathologic hypercapnia can occur.^3,4

Ventilatory Response to Hypercarbia

• The ventilatory response to hypercarbia is linear within normal clinical limits (Figure 1).

• The respiratory center is stimulated by high PaCO₂, low arterial pH, and high CSF PCO₂.
  • High PaCO₂ activates both the peripheral chemoreceptors (carotid bodies at the bifurcation of the carotid artery and aortic bodies on the aortic arch).
  • Acidosis (pH less than 7.35) stimulates only the carotid bodies.
  • High CSF PCO₂, resulting in a low central chemoreceptor extracellular pH, activates the central chemoreceptors.
• The peripheral chemoreceptors are only responsible for 20% of the body’s response to hypercarbia, while the central chemoreceptors are responsible for the remaining 80%. However, the peripheral chemoreceptors respond more rapidly, within 1-3 seconds.
• Anesthetic agents have a depressant effect on the respiratory center and the peripheral chemoreceptors, leading to reduced ventilatory response to both hypercarbia and hypoxemia. (curve shifted to the right).
• Opioids do not affect the response of the peripheral or central chemoreceptors to hypoxia or hypercarbia. Instead, they depress the medullary respiratory center.

Etiologies of Hypercarbia^1-4,8

Pathophysiology

• Acid-base: Elevated PaCO₂ leads to respiratory acidosis. Severe acidosis impairs myocardial contractility, causes vasodilation, and decreases catecholamine responsiveness.^10,11
• Respiratory: Initial hypercapnia stimulates ventilation; prolonged exposure depresses drive. Mild elevations can improve V/Q matching but worsen pulmonary hypertension if excessive.^7,11
• Cardiovascular: Moderate hypercapnia increases heart rate and cardiac output via sympathoadrenal activation, but severe acidosis decreases contractility.²
• Neurologic: Elevated PaCO₂ leads to cerebral vasodilation, increasing cerebral blood flow and intracranial pressure (ICP), which may be a desired or undesired effect in neuroanesthesia or intracranial pathologies.⁹
• Inflammatory: CO₂ modulates cytokine release (↓ IL-6, TNF-α) and neutrophil activity; early hypercapnia may be anti-inflammatory, but prolonged exposure can worsen infection control.⁷

Clinical Presentation⁸

Monitoring

• Respiratory depression thresholds: The American Society of Anesthesiologists includes hypercarbia (PaCO₂ more than 50 mm Hg) as a diagnostic marker for opioid-induced respiratory depression.⁴
• The ASA recommends that all patients receiving neuraxial opioids be monitored for the adequacy of ventilation, including respiratory rate, depth of respiration (assessed without disturbing a sleeping patient), oxygenation (via pulse oximetry), and level of consciousness.⁴

Anesthetic Management

Ensure Adequate Oxygenation

• If the patient’s oxygen saturation is low or decreasing, administer supplemental oxygen and increase the fraction of inspired oxygen.
• The target oxygen saturation is 90-93% or a PaO₂ of 60-70 mmHg (UpToDate article)

Ensure Adequate Ventilation

• If the patient is breathing spontaneously
• Ensure a patent airway
  • Consider using reversal agents (e.g., naloxone, flumazenil) if appropriate
  • Consider bag-mask ventilation, non-invasive ventilation, or endotracheal intubation, depending on the patient’s status.
• If the patient is being mechanically ventilated
  • Increase the minute ventilation and FiO₂ (if the patient is hypoxic)
  • Attempt to hand-ventilate the patient with an alternative device (e.g., self-inflating bag)
  • Rule out an incompetent valve in the breathing circuit or anesthesia machine
  • Rule out an exhausted CO₂ absorbent

Check the Inspired CO₂ Level

• More than 1-2 mmHg of inspired CO₂ indicates rebreathing of CO₂.
• Replace the exhausted CO₂ absorbent (if applicable).
• Troubleshoot the incompetent valve in the breathing circuit or anesthesia machine.

Obtain an Arterial Blood Gas to Confirm Hypercapnia

Rule Out Causes of Increased CO₂ Production

• Rule out sepsis, pyrexia, shivering, malignant hyperthermia, etc.
• Treat the underlying cause.

Special Considerations

Hypercarbia in the Postoperative Period

• Ensure a patent airway
• Consider using reversal agents (e.g., naloxone, flumazenil) if appropriate.
• Ensure adequate reversal of neuromuscular blockade
• Check for syringe or ampoule swap (medication errors)
• Consider bag-mask ventilation, non-invasive ventilation, or endotracheal intubation, depending on the patient’s status.

Permissive Hypercapnia: See OA summary for more details. Link